Pubblicazioni

What is optimal nutritional support in acutely ill cancer patients? More may not be better

2021 - ANNALS OF ONCOLOGY

Bargetzi, L.; Laviano, A.; Stanga, Z.; Schuetz, P.

Nutritional support reduces mortality in hospitalized patients with different types of cancers: secondary analysis of a prospective randomized trial.

2021 - ANNALS OF ONCOLOGY

Bargetzi, L.; Brack, C.; Herrmann, J.; Bargetzi, A.; Hersberger, L.; Bargetzi, M.; Kaegi-Braun, N.; Tribolet, P.; Gomes, F.; Hoess, C.; Pavlicek, V.; Bilz, S.; Sigrist, S.; BrÃ¤ndle, M.; Henzen, C.; Thomann, R.; Rutishauser, J.; Aujesky, D.; Rodondi, N.; DonzÃ©, J.; Laviano, A.; Stanga, Z.; Mueller, B.; Schuetz, P.

10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status

2021 - ANNALS OF ONCOLOGY

Cortellini, A.; Filetti, M.; Citarella, F.; Giusti, R.; Russano, M.; Grossi, F.; Gelibter, A. J.; Pecci, F.; De Tursi, M.; Macerelli, M.; Nigro, O.; Ferrara, M. G.; Buti, S.; Mazzoni, F.; Cantini, L.; Migliorino, M. R.; Addeo, A.; Adamo, V.; Russo, A.; Pinato, D. J.

966P Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy

2021 - ANNALS OF ONCOLOGY

Cortellini, A.; Mallardo, D.; Cleary, S.; Bersanelli, M.; Santini, D.; Tucci, M. G.; Russo, A.; Rastelli, F.; Filetti, M.; Gelibter, A. J.; Marconcini, R.; Chiari, R.; Grossi, F.; De Tursi, M.; Queirolo, P.; Zoratto, F.; Tanda, E. T.; Porzio, G.; Ascierto, P. A.; Pinato, D. J.

EANOâESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours â

2021 - ANNALS OF ONCOLOGY

Le Rhun, E.; Guckenberger, M.; Smits, M.; Dummer, R.; Bachelot, T.; Sahm, F.; Galldiks, N.; de Azambuja, E.; Berghoff, A. S.; Metellus, P.; Peters, S.; Hong, Y. -K.; Winkler, F.; Schadendorf, D.; van den Bent, M.; Seoane, J.; Stahel, R.; Minniti, G.; Wesseling, P.; Weller, M.; Preusser, M.

Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification

2020 - ANNALS OF ONCOLOGY

Mazzotta, M.; Filetti, M.; Rossi, A.; Roberto, M.; Occhipinti, M.; Pernazza, A.; Di Napoli, A.; Scarpino, S.; Vecchione, A.; Giusti, R.; Marchetti, P.

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

2020 - ANNALS OF ONCOLOGY

Marinelli, D; Mazzotta, M; Scalera, S; Terrenato, I; Sperati, F; D'Ambrosio, L; Pallocca, M; Corleone, G; Krasniqi, E; Pizzuti, L; Barba, M; Carpano, S; Vici, P; Filetti, M; Giusti, R; Vecchione, A; Occhipinti, M; Gelibter, A; Botticelli, A; De Nicola, F; Ciuffreda, L; Goeman, F; Gallo, E; Visca, P; Pescarmona, E; Fanciulli, M; De Maria, R; Marchetti, P; Ciliberto, G; Maugeri-SaccÃ , M

1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program

2020 - ANNALS OF ONCOLOGY

Prelaj, A.; Bottiglieri, A.; Proto, C.; Lo Russo, G.; Signorelli, D.; Ferrara, R.; Galli, G.; De Toma, A.; Viscardi, G.; Brambilla, M.; Lobefaro, R.; Manglaviti, S.; Occhipinti, M.; Labianca, A.; Gallucci, R.; Molino, G.; Zilembo, N.; Greco, F. G.; Torri, V.; Garassino, M. C.

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

2020 - ANNALS OF ONCOLOGY

Marinelli, D.; Mazzotta, M.; Scalera, S.; Terrenato, I.; Sperati, F.; D'Ambrosio, L.; Pallocca, M.; Corleone, G.; Krasniqi, E.; Pizzuti, L.; Barba, M.; Carpano, S.; Vici, P.; Filetti, M.; Giusti, R.; Vecchione, A.; Occhipinti, M.; Gelibter, A.; Botticelli, A.; De Nicola, F.; Ciuffreda, L.; Goeman, F.; Gallo, E.; Visca, P.; Pescarmona, E.; Fanciulli, M.; De Maria, R.; Marchetti, P.; Ciliberto, G.; Maugeri-Sacca, M.

IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells

2020 - ANNALS OF ONCOLOGY

Ugolini, A; Zizzari, Ig; Ceccarelli, F; Botticelli, A; Colasanti, T; Strigari, L; Rughetti, A; Rahimi, H; Conti, F; Valesini, G; Marchetti, P; Nuti, M

[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia

2020 - ANNALS OF ONCOLOGYANNALS OF ONCOLOGY

Rinzivillo, M; Prosperi, D; Mazzuca, F; Magi, L; Iannicelli, E; Pilozzi, E; Franchi, G; Silveri, Gg; Laghi, A; Annibale, B; Signore, A; Panzuto, F

Bone health in cancer: ESMO Clinical Practice Guidelines

2020 - ANNALS OF ONCOLOGY

Coleman, R; Hadji, P; Body, Jj; Santini, D; Chow, E; Terpos, E; Oudard, S; Bruland, O; Flamen, P; Kurth, A; Van Poznak, C; Aapro, M; Jordan, K

The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC).

2020 - ANNALS OF ONCOLOGY

Arrivi, G.; Marchetti, P.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; IerinoÌ, D.; Panebianco, M.; Mazzuca, F.; Roberto, M.

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group

2020 - ANNALS OF ONCOLOGY

De Mattos-Arruda, L; Vazquez, M; Finotello, F; Lepore, R; Porta, E; Hundal, J; Amengual-Rigo, P; Ng, C K Y; Valencia, A; Carrillo, J; Chan, T A; Guallar, V; Mcgranahan, N; Blanco, J; Griffith, M

Advances in targeted Alpha therapy for prostate cancer

2019 - ANNALS OF ONCOLOGY

De Vincentis, G; Gerritsen, W; Gschwend, J E; Hacker, M; Lewington, V; O'Sullivan, J M; Oya, M; Pacilio, M; Parker, C; Shore, N; Sartor, O

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2019 - ANNALS OF ONCOLOGY

Filetti, S; Durante, C; Hartl, D; Leboulleux, S; Locati, L D; Newbold, K; Papotti, M G; Berruti, A

A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy

2019 - ANNALS OF ONCOLOGY

Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; DellâAquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Ficorella, C.; Cannita, K.

A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation

2019 - ANNALS OF ONCOLOGY

Manca, P; Mallona, I; Santini, D; Tonini, G; Rolfo, Cd; Robinson, Md; Pantano, F

REDOXI-miRNA of Keap1/Nrf2 axis in lung tumors

2019 - ANNALS OF ONCOLOGY

Fabrizio, Fp; Sparaneo, A; Castellana, S; Mazza, T; Trombetta, D; Graziano, P; Rossi A, ; Fazio, Vm; Muscarella, La

New insights in the antitumor effects of Î²-caryophyllene in breast cancer cells: The role of cannabinoid and adrenergic systems

2018 - ANNALS OF ONCOLOGY

Di Sotto, A.; Romaniell, D.; Freddoni, G.; Abete, L.; Cocchiola, R.; Di Giacomo, S.; Altieri, F.; Mazzanti, G.; Eufemi, M.

Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients

2018 - ANNALS OF ONCOLOGY

Raponi, S; Del Giudice, I; Marinelli, M; Wang, J; Cafforio, L; Ilari, C; Piciocchi, A; Messina, M; Bonina, S; Tavolaro, S; Bordyuh, M; Mariglia, P; Peragine, N; Mauro, F R; Chiaretti, S; Molica, S; Gentile, M; Visentin, A; Trentin, L; Rigolin, G M; Cuneo, A; Diop, F; Rossi, D; Gaidano, G; Guarini, A; Rabadan, R; FoÃ , R

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO

2018 - ANNALS OF ONCOLOGY

Cremolini, C; Antoniotti, C; Lonardi, S; Bergamo, F; Cortesi, E; Tomasello, G; Moretto, R; Ronzoni, M; Racca, P; Loupakis, F; Zaniboni, A; Tonini, G; Buonadonna, A; Marmorino, F; Allegrini, G; Granetto, C; Masi, G; Zagonel, V; Sensi, E; Fontanini, G; Boni, L; Falcone, A

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER studyâ¡

2018 - ANNALS OF ONCOLOGY

Conte, P; Frassoldati, A; Bisagni, G; Brandes, A A; Donadio, M; Garrone, O; Piacentini, F; Cavanna, L; Giotta, F; Aieta, M; Gebbia, V; Molino, A; Musolino, A; Ferro, A; Maltoni, R; Danese, S; Zamagni, C; Rimanti, A; Cagossi, K; Russo, A; Pronzato, P; Giovanardi, F; Moretti, G; Lombardo, L; Schirone, A; Beano, A; Amaducci, L; Bajardi, E A; Vicini, R; Balduzzi, S; D'Amico, R; Guarneri, V

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO

2018 - ANNALS OF ONCOLOGY

Dell'Aquila, E; Cremolini, C; Zeppola, T; Lonardi, S; Bergamo, F; Masi, G; Stellato, M; Marmorino, F; Schirripa, M; Urbano, F; Ronzoni, M; Tomasello, G; Zaniboni, A; Racca, P; Buonadonna, A; Allegrini, G; Fea, E; Di Donato, S; Chiara, S; Tonini, G; Tomcikova, D; Boni, L; Falcone, A; Santini, D

Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach

2018 - ANNALS OF ONCOLOGY

Falcone, R.; Paci, P.; Verrienti, A.; Fiscon, G.; Sponziello, M.; Conte, F.; Pecce, V.; Rosignolo, F.; Grani, G.; Lamartina, L.; Ramundo, V.; Durante, C.; Farina, L.; Filetti, S.